Positron-Emission Tomography and Assessment of Cancer Therapy
Top Cited Papers
- 2 February 2006
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (5) , 496-507
- https://doi.org/10.1056/nejmra050276
Abstract
Positron-emission tomography (PET) is a noninvasive imaging technique that exploits the unique decay physics of positron-emitting isotopes. The isotopes of oxygen, carbon, nitrogen, and fluorine have been used in the development of diagnostically useful biologic compounds that are available for PET imaging in order to provide a functional or metabolic assessment of normal tissues or disease conditions.The past few years have seen a tremendous expansion of clinical applications of PET, particularly in oncology, mostly with the use of 18F-fluorodeoxyglucose (18F-FDG) as the PET tracer. PET with 18F-FDG is now being used in the evaluation of several neoplasms, both . . .Keywords
This publication has 45 references indexed in Scilit:
- Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission TomographyJournal of Clinical Oncology, 2005
- Role of Positron Emission Tomography in LymphomaJournal of Clinical Oncology, 2005
- Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMolecular Imaging & Biology, 2004
- Positron emission tomography versus positron emission tomography/computed tomography: from “unclear” to “new-clear” medicineMolecular Imaging & Biology, 2004
- Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinomaBritish Journal of Surgery, 2004
- Utility of FDG-PET scanning in lymphoma by WHO classificationBlood, 2003
- A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen LevelsAnnals of Surgical Oncology, 2001
- Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancerEuropean Respiratory Journal, 1999
- Possible Role of FDG-PET in the Early Prediction of Therapy Outcome in Liver Metastases of Colorectal CancerHybridoma, 1999
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996